Related Article
- Government Bans Telegram Till June 22 Ahead of NEET-UG 2026 Re-Test to Prevent Cheating
- Indian PM Modi seeks to strengthen ties in Slovakia
- Why Are Suicide Cases Rising in Indore? NCRB Data Reveals a Disturbing Trend
- US-Iran Deal Lowers Crude Oil Prices: When Will Petrol and Diesel Become Cheaper in India?
- Will India Escape El Nino's Wrath? Experts Pin Hopes on Indian Ocean Dipole
Cough Syrups Now Require Doctor's Prescription as Government Tightens Drug Safety Rules
In a major move aimed at strengthening drug safety and regulatory oversight, the Union Health Ministry has made it mandatory for consumers to obtain a doctor's prescription before purchasing syrup-based medicines, including cough syrups.
The decision comes amid growing concerns over medicine quality and patient safety, particularly following reports linking contaminated cough syrups to child deaths in parts of the country.
The new regulation has been notified through the Drugs (Fifth Amendment) Rules, 2026, published in the Official Gazette, and has come into effect immediately.
The new regulation has been notified through the Drugs (Fifth Amendment) Rules, 2026, published in the Official Gazette, and has come into effect immediately.
What Has Changed?
Under the amendment, the government has removed the term "Syrups" from Schedule K of the Drugs Rules, 1945. Schedule K contains a list of medicines that are exempt from certain provisions governing their sale and distribution under specific conditions.
Under the amendment, the government has removed the term "Syrups" from Schedule K of the Drugs Rules, 1945. Schedule K contains a list of medicines that are exempt from certain provisions governing their sale and distribution under specific conditions.
With the exemption removed, syrup-based medicines, including commonly used cough syrups, will now fall under stricter regulatory controls and can no longer be sold over the counter without a valid medical prescription.
The official notification states that the amendment was introduced after considering public feedback received on a draft proposal released in December 2025.
The official notification states that the amendment was introduced after considering public feedback received on a draft proposal released in December 2025.
The Health Ministry also clarified that the rules were framed after consultation with the Drugs Technical Advisory Board under the powers granted by the Drugs and Cosmetics Act, 1940.
Safety Concerns Behind the Decision
Safety Concerns Behind the Decision
The government's move follows heightened scrutiny of syrup-based medicines after contaminated cough syrups were allegedly linked to the deaths of several children in Madhya Pradesh and Rajasthan.
The incidents reignited concerns about quality control standards, manufacturing practices, and regulatory monitoring of liquid medicines sold across the country.
The incidents reignited concerns about quality control standards, manufacturing practices, and regulatory monitoring of liquid medicines sold across the country.
Health experts and consumer groups had since been calling for tighter checks on the production, distribution, and sale of medicinal syrups to prevent similar tragedies.
Impact on Consumers
The new rules mean that consumers will no longer be able to purchase cough syrups and other medicinal syrups directly from pharmacies without medical authorization.
Impact on Consumers
The new rules mean that consumers will no longer be able to purchase cough syrups and other medicinal syrups directly from pharmacies without medical authorization.
A valid prescription issued by a registered medical practitioner will now be required to buy such medicines.
The change is expected to significantly alter the routine sale of cough and syrup-based medications, many of which have traditionally been available without a prescription in several parts of the country.
The change is expected to significantly alter the routine sale of cough and syrup-based medications, many of which have traditionally been available without a prescription in several parts of the country.
Officials believe the move will help improve patient safety, reduce misuse, and ensure better monitoring of medicines that are widely consumed by both adults and children.
